The Allstate Corporation
NYSE:ALLInsurance - Property & Casualty
-$2.30 today
- Market cap
- $65.97B
- Beta
- 0.19
- P/E (TTM)
- 4.7
- EPS (TTM)
- $46.82
- Dividend yield
- 1.90%
Volume 1.38M
Average 1.52M
ALL EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
The Allstate CorporationNYSE: ALL
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA grows, but more slowly than its trailing trend
Q2 FY2026 EBITDA of $4.32B rose 47.4% year over year, behind the +116.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 29.6% from the prior quarter.
Context
- EBITDA amounted to 21.1% of revenue in FY2025, up 10.5 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of $16.69B (+18.9%) for the fiscal year ending Dec 2026, a slowdown from the +109.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $4.32B+29.6% QoQ
- Last fiscal yearDec 2025
- $14.04B+109.0% YoY
- LTMJun 2026
- $17.81B+116.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +47.4% | -41.8% | -89.2 pp |
| 1 year | +109.0% | +18.9% | -90.1 pp |
| 3-year CAGR | — | -8.4% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 14.04B USD
- Year-over-year change
- +109.0%
- 4-year CAGR
- +15.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.04B | +109.0% |
| FY2024 | 2024-12-31 | 6.72B | +813.7% |
| FY2023 | 2023-12-31 | 735M | +213.4% |
| FY2022 | 2022-12-31 | (648M) | -108.2% |
| FY2021 | 2021-12-31 | 7.88B | — |
EBITDA vs competitors
How ALL compares with its peers on the latest reported figures
- ALL's LTM Jun 2026 EBITDA of $17.81B is the highest of the 11 companies compared; the peer median is $2.2B.
- Its year-over-year change of +116.0% is the highest of 11, against a peer median of +5.7%.
- EBITDA amounts to 25.7% of revenue for ALL, versus a peer median of 15.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $17.81B | +116.0% | — | 25.7% | |
| LTM Sep 2026 | $15.25B | +8.2% | +115.9% | 16.6% | |
| LTM Sep 2026 | $11.71B | -13.0% | +24.3% | 18.9% | |
| LTM Sep 2026 | $11.52B | +37.6% | +25.2% | 23.5% | |
| LTM Sep 2026 | $3.55B | -27.7% | +22.9% | 12.2% | |
| LTM Sep 2026 | $2.91B | +3.3% | — | 21.9% | |
| LTM Sep 2026 | $1.5B | +2.3% | +23.2% | 9.9% | |
| LTM Sep 2026 | $943.1M | +13.5% | +66.5% | 13.8% | |
| LTM Sep 2026 | $672.68M | +14.6% | +24.1% | 12.4% | |
| LTM Sep 2026 | $520.91M | +13.8% | -10.4% | 26.8% | |
| LTM Mar 2026 | $93.41M | -8.5% | +26.5% | 7.4% | |
| Peer median (excluding ALL) | $2.2B | +5.7% | +24.3% | 15.2% | |
Competitors are the stored peer set for ALL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 48.68B | 50.62B | 56.59B | 63.52B | 66.46B |
| Cost of Revenue | 36.65B | 44.94B | 49.42B | 49.02B | 44.37B |
| Gross Profit | 12.03B | 5.68B | 7.17B | 14.5B | 22.09B |
| Gross Margin | 24.7% | 11.2% | 12.7% | 22.8% | 33.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | (644M) | 116M | 9M | (37M) | (30M) |
| Operating Expenses | 5.57B | 7.51B | 7.52B | 8.74B | 8.93B |
| Depreciation & Amortization | 1.09B | 847M | 704M | 555M | 482M |
| EBITDA | 7.88B | (648M) | 735M | 6.72B | 14.04B |
| EBITDA Margin | 16.2% | -1.3% | 1.3% | 10.6% | 21.1% |
| Operating Income | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Operating Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 330M | 335M | 379M | 400M | 399M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 6.47B | (1.83B) | (348M) | 5.76B | 13.16B |
| Pre-Tax Margin | 13.3% | -3.6% | -0.6% | 9.1% | 19.8% |
| Income Tax Expense | 1.29B | (488M) | (135M) | 1.16B | 2.89B |
| Net Income | 1.61B | (1.29B) | (188M) | 4.67B | 10.28B |
| Net Margin | 3.3% | -2.5% | -0.3% | 7.3% | 15.5% |
| EPS (Basic) | 5.04 | (5.03) | (1.20) | 17.22 | 38.68 |
| EPS (Diluted) | 4.96 | (5.03) | (1.20) | 16.99 | 38.19 |
| Weighted Avg Shares | 294.8M | 271.2M | 262.5M | 264.3M | 261.3M |
| Weighted Avg Shares (Diluted) | 299.1M | 271.2M | 262.5M | 267.8M | 264.7M |
The Allstate Corporation
NYSE:ALL
Intrinsic Alpha fair value
Locked
Current Price
$266.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.